![Clinton Musil](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Clinton Musil
Finanzdirektor/CFO bei
Skyhawk Therapeutics, Inc.
Profil
Clinton Musil currently works at Skyhawk Therapeutics, Inc., as President & Chief Financial Officer.
Mr. Musil also formerly worked at Wells Fargo & Co., as Vice President-Healthcare Investment Banking Group from 2013 to 2014, Deutsche Bank AG, as Vice President-Healthcare Investment Banking Group from 2014 to 2017, Personalis, Inc., as Chief Business Officer, Needham & Co. LLC, as Principal, Essex Woodlands Management, Inc., as Vice President, ARMO BioSciences, Inc., as Vice President-Corporate Development from 2017 to 2018, Catalyst Biosciences, Inc., as Chief Financial Officer from 2020 to 2021, and Skyhawk Therapeutics, Inc., as Chief Financial Officer from 2021 to 2024.
Mr. Musil received his undergraduate degree from the University of Arizona and Masters Business Admin degree from Harvard Business School.
Aktive Positionen von Clinton Musil
| Unternehmen | Position | Beginn |
|---|---|---|
Skyhawk Therapeutics, Inc.
 Skyhawk Therapeutics, Inc. BiotechnologyHealth Technology Develops novel RNA-targeting small molecule for neurology, oncology and fibrotic diseases | Finanzdirektor/CFO | 30.11.2024 |
Ehemalige bekannte Positionen von Clinton Musil
| Unternehmen | Position | Ende |
|---|---|---|
Skyhawk Therapeutics, Inc.
Skyhawk Therapeutics, Inc. BiotechnologyHealth Technology Develops novel RNA-targeting small molecule for neurology, oncology and fibrotic diseases | Finanzdirektor/CFO | 01.02.2024 |
| CATALYST BIOSCIENCES | Finanzdirektor/CFO | 29.10.2021 |
| ARMO BIOSCIENCES INC | Corporate Officer/Principal | 01.07.2018 |
| DEUTSCHE BANK AG | Corporate Officer/Principal | 01.03.2017 |
| WELLS FARGO & COMPANY | Corporate Officer/Principal | 01.07.2014 |
Ausbildung von Clinton Musil
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
85
Beziehungen ersten Grades
10
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 10 |
|---|---|
Wells Fargo & Co.
 Wells Fargo & Co. Major BanksFinance Operates as a bank holding company whose subsidiaries provides consumer, commercial, corporate, investment banking and wealth management services | Finance |
Deutsche Bank AG
 Deutsche Bank AG Investment Banks/BrokersFinance Provides investment and corporate banking & asset management services | Finance |
Personalis, Inc.
 Personalis, Inc. Medical/Nursing ServicesHealth Services Operates as a cancer genomics company which transforms the development of next-generation therapies | Health Services |
Needham & Co. LLC
 Needham & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
University of Arizona
 University of Arizona Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Essex Woodlands Management, Inc.
 Essex Woodlands Management, Inc. Investment ManagersFinance EW Healthcare Partners invests in public and private companies located in the North America, Latin America, Asia, and Europe with revenues ranges from USD 20 - 200 million. The firm focuses on sectors such as pharmaceutical, medical device, healthcare services, and healthcare IT. The firm participates in growth capital requirements with an investment size range from USD 20 - 100 million. It takes minority or majority interest and requires a board position. | Finance |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ARMO BioSciences, Inc.
 ARMO BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Develops immunotherapy for treatment of cancer | Health Technology |
Catalyst Biosciences, Inc.
 Catalyst Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
Skyhawk Therapeutics, Inc.
Skyhawk Therapeutics, Inc. BiotechnologyHealth Technology Develops novel RNA-targeting small molecule for neurology, oncology and fibrotic diseases | Health Technology |
